Aggression - 371 Studies Found Active, not recruiting : Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer : Prostate Cancer : 2012-01-17 Completed : Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis : Rheumatoid Arthritis : 2005-12-19 : Other: as clinical practice Dosage, form, frequency and duration as per ordinary clinical practice Recruiting : Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease : Sickle Cell Disease : 2017-04-14 : Drug: ATG 0.5 mg/kg IV on day Completed : Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas : Peripheral T-Cell Lymphomas Non-Hodgkin Lymphoma : 2006-09-07 : Drug: Velcade Recruiting : Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma : Lymphoma : 2015-05-04 : Drug: Ibrutinib Drug: Rituximab Completed : YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering : Obstructive Coronary Artery Disease Coronary Artery Disease : 2013-04-05 : Drug: rosuvastatin All subjects will receive rosuvastatin 40mg/day for 8-12 weeks Completed : Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis : Multiple Sclerosis : 2010-10-04 : Procedure: plasmapheresis 3 courses of plasmapheresis are performed before mitoxantrone injection in fir Completed : Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma : Non-Hodgkin's Lymphoma : 2007-06-21 : Drug: gemcitabine Drug: cisplatin Recruiting : Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas : B-cell Lymphoma : 2013-02-04 : Drug: Lenalidomide Completed : Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma : Non-Hodgkin Lymphoma : 2001-11-14 <<< Previous | Next >>>
